Your browser is no longer supported. Please, upgrade your browser.
XBI SPDR S&P Biotech ETF daily Stock Chart
SPDR S&P Biotech ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-1.21%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-0.36%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter7.58%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio4.12 Perf Half Y27.66%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-18.08%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range44.12 - 80.35 Perf YTD-12.89%
Dividend0.30 P/FCF- EPS past 5Y- ROI- 52W High-23.96% Beta-
Dividend %0.49% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low38.47% ATR1.64
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)50.17 Volatility3.59% 2.56%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.37 Prev Close60.39
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume7.36M Price61.10
Recom- SMA20-2.43% SMA504.01% SMA2006.05% Volume10,098,289 Change1.18%
Aug-26-16 10:27AM  Biotech ETFs in Focus After Mylan's EpiPen Controversy
08:04AM  Could Zinbryta Become a Novel Immunomodulatory Therapy for MS?
Aug-25-16 02:14PM  Clinton Mylan Attack Reminds Biotech ETF Investors of Election Risks
Aug-24-16 02:37PM  How Advisors Evaluate Industry, Sector ETFs
11:04AM  Medivation: The Latest Analyst Recommendations
Aug-23-16 08:16AM  It Could Be An Interesting Ride For Healthcare ETFs
Aug-22-16 12:46PM  Medivation shareholders should be thrilled about price of Pfizer deal: analysts at MarketWatch
Aug-17-16 06:46AM  Healthcare Investors May Be Pricing In A Clinton Victory
Aug-16-16 12:36PM  Charting the U.S. benchmarks pulling-teeth breakout attempt at MarketWatch
11:08AM  Tuesday links: operating in silos
06:07AM  US Consumer Sentiment Is Below the Forecast
Aug-15-16 02:58PM  Bulls are chasing uptrend in biotech fund
11:58AM  Biotech Stocks: The Rebirth of the Bull? at
Aug-11-16 11:58AM  Active Traders Turn Bullish on Biotech at Investopedia
Aug-09-16 10:15AM  Crushed Bio-Tech leader falls 90%, now attempting breakout
Aug-06-16 11:16AM  The Week Ahead: Is Macro Really Wacko? at Forbes
Aug-05-16 09:07AM  Why Markets Remained Range Bound after US Data Release
Aug-04-16 10:00AM  Amid Biotech Rally, Investors Show Jitters
Aug-02-16 05:00PM  Biogen surges on takeover talk. 4 Trades
04:09PM  2 Biotech Funds Leading Nascent Bull Market: Which Is Right For You?
09:08AM  Is BioMarin Set to Become Profitable in 2017?
09:05AM  How Significant Is Alexions Opportunity with Soliris?
07:57AM  Weak US Data: ISM Manufacturing PMI and Construction Spending
06:59AM  Talk about risk on: The unpredictable biotech sector just entered a bull market at MarketWatch
Aug-01-16 12:33PM  Why Did the US Dollar Index Fall Last Week?
12:33PM  Biotech bounce
10:22AM  Investor buys time for a rally in biotechs
Jul-30-16 11:12AM  The Week Ahead: Bull Sheds Sheep's Clothing at Forbes
Jul-29-16 11:58AM  Biotech Stocks: The End of Political Risk? at
11:21AM  Best ETFs of July
Jul-28-16 01:58PM  Celgene Set to Squeeze Short Sellers (CELG, IBB) at Investopedia
09:11AM  FOMC Keeps the Door Open for a Live Meeting in September
07:00AM  A Trump win could also be a win for these volatile stocks at CNBC
Jul-25-16 12:06PM  Yee: Biotech stocks will outperform after election
12:00PM  Bracing for a 'bio-wreck'?
05:00AM  This Week Could Decide Whether Biotech ETFs' Rally Sizzles Or Fizzles
Jul-22-16 01:12PM  Will Orenitram Lose Market Share to Uptravi in 2016?
Jul-21-16 12:00PM  Is biotech back?
Jul-19-16 04:21PM  Earnings Estimates for These 3 Biotech Giants Should Be Heading Lower -- Here's Why at Motley Fool
Jul-18-16 11:07AM  How Much Potential Does Promacta Hold?
Jul-14-16 01:11PM  Ligand Pharmaceuticalss Performance Based on EV-to-EBITDA
11:05AM  ALNY Reports Positive Results from Open Label Extension Study of Revusiran
Jul-13-16 02:35PM  New Stock Market Highs Fighting Many More Outside Pressures Than Usual: Time to Panic? at 24/7 Wall St.
09:00AM  Biotech ETFs: Will the Once Hot Group Rebound?
Jul-07-16 12:18PM  Strong ISM Non-Manufacturing PMI Overshadows Services PMI
Jul-05-16 11:05AM  AbbVies Tests of Imbruvica with Venclexta for Oncology Therapy
Jul-01-16 04:06PM  Biotech Bottom Calls After Big Bounce (IBB, XBI) at Investopedia
11:07AM  What Are the Benefits of the Novartis-Xencor Alliance to Xencor?
07:01AM  Biotech Stock Mailbag: Mid-Year Assessment, Where We Go From Here
Jun-30-16 06:33PM  Biotechs Building Base?...Or Bursting Bubble?
03:54PM  How Did Investors Respond to the Novartis-Xencor Alliance?
03:54PM  The Novartis-Xencor Collaboration Agreement: The Details
02:21PM  Hedge Funds Like ETFs Too
08:21AM  US Inflation Numbers Are Decent, Brexit Clouds Future Outlook
Jun-29-16 07:00AM  US GDP and Consumer Confidence: Is a Revival Coming?
Jun-26-16 07:21AM  The 5 Best Healthcare ETFs at Motley Fool
Jun-24-16 09:56AM  Brexit means little for biotech stocks, analyst says at MarketWatch
Jun-22-16 02:07PM  Traders Get It Right (Sort Of) With Leveraged Biotech ETFs
Jun-21-16 01:09PM  Bio Tech; Market leader testing breakdown level
Jun-16-16 10:46AM  Why Does XBIs Loss Continue to Widen?
Jun-15-16 11:50AM  Biotech: It's the Election, Silly at
09:16AM  Cellectar's stock soars after positive results of a study of its tumor treatment at MarketWatch
Jun-14-16 03:32PM  Biotech: Still Troubled at
07:00AM  IBB & XBI: Should You Short the Biotech Industry? at Investopedia
Jun-13-16 02:00PM  3 Cases When Not to Place Tight Stop-Loss Orders (IBB, XBI) at Investopedia
09:06AM  How Are XBIs Holdings Moving Averages Trending?
Jun-10-16 03:58PM  Downside Ahead For Biotech Stocks?
Jun-07-16 12:44PM  Yellen Upbeat on Economy: Wining Sector ETFs
12:33AM  Biotech Bounce: Sizzle Or Fizzle?
Jun-06-16 03:34PM  How Did Biotech ETFs Perform in the Week Ended June 3?
07:47AM  Exelixis's stock surges after positive results from trial of kidney cancer treatment at MarketWatch
Jun-03-16 01:20PM  The buzz from ASCO
11:22AM  ADP Unemployment Change Decent: Initial Jobless Claims Fall
09:06AM  Heres What Else Is Happening Now for Ionis
08:00AM  Trying to Believe in Biotech ETFs
Jun-02-16 04:08PM  6 Biotechs Seriously on the Move at 24/7 Wall St.
10:23AM  Biotech Stocks: Don't Expect a 'Miraculous Recovery' at
07:51AM  A.M. Funds Roundup: DoubleLine Hits $100B; Big Trading in Small-Cap Index Funds at
Jun-01-16 06:07PM  Inside Ioniss Key Pipeline Drug IONIS-TTR
09:23AM  3 High-Growth ETFs to Supercharge Your Portfolio at Motley Fool
May-31-16 05:58PM  What Happened to Ioniss Revenues in 1Q16?
03:26PM  A Lesson in Biotech Risk at
09:21AM  XBI Tops the Biotechnology ETFs in the Last Week of May
May-27-16 02:05PM  XBI Mid-Caps: Seattle Genetics Rose Due to Higher Trading Volumes
01:11PM  This Biotech ETF Could Be Ready To Party
01:02PM  3 Highly Rated IBD Stocks Powering A Top Biotech ETFs Revival
May-23-16 05:44PM  Markets Rise as Fed Member James Bullard Exhibits Hawkish Stance
May-19-16 12:16PM  XBI Large-Caps: Why Is BioMarin Inching Higher?
12:16PM  Markets Are Defensive: XBI Outperforms the Market
May-17-16 11:40AM  Biotech ETFs Soar on Pfizer-Anacor Deal: SBIO, XBI in Lead
May-16-16 10:07AM  Analyzing XBI Mid-Caps: Intrexon Fell Due to 1Q16 Loss
10:06AM  What Do Analysts Recommend for Medivation?
May-13-16 04:48PM  What Lies Ahead for Biotech ETFs?
May-12-16 12:13PM  Inside XBI Large-Caps: European Commission Approves of Empliciti
12:13PM  XBI Dropped, Markets Fell Due to Retail Sector Concerns
May-10-16 04:13PM  Why Did Medivations Share Price Increase so Much after Earnings?
07:00AM  The Trader Daily: Lots of Stocks Get Drilled at TheStreet
07:00AM  The Trader Daily: Lots of Stocks Get Drilled
May-09-16 06:24PM  Healthcare, Biotech SPDR Indexes Gain on May 9 as US Dollar Rises
04:21PM  Why Celldex Therapeutics, Inc. Popped Today at Motley Fool
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.